-
Animal & Veterinary
-
Swine
Breeding Swine
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Chlortetracycline | N046-699 | Type C | Breeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. |
Finishing Swine
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Ractopamine and Tylosin | N141-172 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 Ibs... and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
Growing Swine
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Chlortetracycline | N046-699 | Type C | For an increased rate of weight gain and improved feed efficiency in growing swine. |
Swine
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Bacitracin Zinc | A200-223 | Type B | For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Bacitracin Zinc | A200-223 | Type C | For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Carbadox | N041-061 | Type B | For control of swine dysentery (vibrionic dysentery, bloody scours by hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency. |
| Carbadox | N041-061 | Type B | For increased rate of weight gain and improved feed efficiency. |
| Carbadox | N041-061 | Type C | For control of swine dysentery (vibrionic dysentery, bloody scours of hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency. |
| Carbadox | N041-061 | Type C | For increased rate of weight gain and improved feed efficiency |
| Chlortetracycline | N046-699 | Type B | For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis... For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms. |
| Chlortetracycline | N046-699 | Type C | For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci |
| Chlortetracycline | N046-699 | Type C | For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis...For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms. |
| Oxytetracycline | N138-938 | Type B | For increased rate of weight gain and improved feed efficiency; treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida; control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona |
| Oxytetracycline | N138-938 | Type C | For increased rate of weight gain and improved feed efficiency |
| Oxytetracycline | N138-938 | Type C | For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida |
| Oxytetracycline | N138-938 | Type C | For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine...; control of swine dysentery associated with Brachyspira hyodysenteriae; and control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine...; and control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis |
| Tiamulin | N139-172 | Type B | For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis; control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin |
| Tiamulin | N139-172 | Type C | For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis and for control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin |
| Tylosin and Sulfamethazine | N041-275 | Type B | For maintaining weight gains and feed efficiency in the presence of atrophic rhinitis; lowering the incidence and severity bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes). |
| Tylosin and Sulfamethazine | N041-275 | Type C | For maintaining weight gains and feed efficiency in the presence of atrophic rhinitis; lowering the incidence and severity bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes |
| Virginiamycin | N091-467 | Type B | Increased rate of weight gain and improved feed efficiency; aid in the control of swine dysentery... for use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred; treatment and control of swine dysentery. |
| Virginiamycin | N091-467 | Type B | Increased rate of weight gain and improved feed efficiency; aid in the control of swine dysentery... for use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred; treatment and control of swine dysentery |
| Virginiamycin | N091-467 | Type C | Increased rate of weight gain and improved feed efficiency... |
| Virginiamycin | N091-467 | Type C | As an aid in the control of swine dysentery in swine weighing up to 120 lb. For use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in swine weighing up to 120 lb |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in non-breeding swine weighing over 120 lb |
| Virginiamycin | N091-467 | Type C | Increased rate of weight gain and improved feed efficiency... |
| Virginiamycin | N091-467 | Type C | As an aid in the control of swine dysentery in swine weighing up to 120 lb. For use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in swine weighing up to 120 lb |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in non-breeding swine weighing over 120 lb |
-
-